NEW YORK (Reuters Health) – Men with azoospermia have a risk of developing cancer 2.9 times higher than the general population, according to data from a Texas andrology…
NEW YORK (Reuters Health) – Contrary to a historically pessimistic outlook, high-risk prostate cancer can be controlled with moderate high-dose radiation treatment and prolonged androgen-deprivation therapy (ADT). That…
NEW YORK (Reuters Health) – An updated meta-analysis supports the strategy of giving intravesical chemotherapy (IVC) immediately after bladder tumor resection to reduce the risk of recurrence. “However,…
NEW YORK (Reuters Health) – Morbidity associated with inguinal lymphadenectomy in patients with penile carcinoma has declined, and is “reasonable” considering the potential benefit, a Brazilian team reports.…
NEW YORK (Reuters Health) – A review of the literature indicates that, far from being futile, radical prostatectomy improves outcomes when lymph nodes (LNs) are found to be…
By Robert Saunders NEW YORK (Reuters Health) – For men with biochemical recurrence of prostate cancer after radical prostatectomy, radiation offers a good chance of cure, according to…
NEW YORK (Reuters Health) – Based on Medicare claims data, the rate of incisional hernia following radical prostatectomy is about three-times higher with minimally invasive surgery than with…
By Genevra Pittman NEW YORK (Reuters Health) – Men who were exposed to Agent Orange chemicals during the Vietnam War are at higher risk for high-grade prostate cancer…
NEW YORK (Reuters Health) – Measuring urinary levels of prostate cancer antigen 3 (PSA3) may be more accurate than PSA testing in detecting prostate cancer, but evidence is…
NEW YORK (Reuters Health) – Anticoagulant use may be a predictor of overall survival in men with metastatic castration-resistant prostate cancer (mCRPC) receiving docetaxel, retrospective data suggest. The…
